Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border
Christina D. Weber, Oliver Krug, Matthias Kamber, et al.
Substance Use & Misuse (2017) Vol. 52, Iss. 6, pp. 742-753
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Designer drugs: mechanism of action and adverse effects
Dino Luethi, Matthias E. Liechti
Archives of Toxicology (2020) Vol. 94, Iss. 4, pp. 1085-1133
Open Access | Times Cited: 214
Fake anabolic androgenic steroids on the black market – a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature
Raphael Magnolini, Luis Falcato, Alessio Cremonesi, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 47
Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids
Diederik L. Smit, Olivier de Hon, Bastiaan J. Venhuis, et al.
Scandinavian Journal of Medicine and Science in Sports (2019) Vol. 30, Iss. 3, pp. 531-539
Closed Access | Times Cited: 55
Positive and negative side effects of androgen abuse. The HAARLEM study: A one‐year prospective cohort study in 100 men
Diederik L. Smit, Madelon M. Buijs, Olivier de Hon, et al.
Scandinavian Journal of Medicine and Science in Sports (2020) Vol. 31, Iss. 2, pp. 427-438
Closed Access | Times Cited: 46
Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution
Patrik Olekšák, Eugenie Nepovimová, Marián Valko, et al.
Environmental Toxicology and Pharmacology (2024) Vol. 108, pp. 104447-104447
Closed Access | Times Cited: 5
Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study
Diederik L. Smit, Madelon M. Buijs, Olivier de Hon, et al.
Human Reproduction (2020) Vol. 36, Iss. 4, pp. 880-890
Open Access | Times Cited: 35
Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents
Annica Börjesson, Mikael Lehtihet, Alexander Andersson, et al.
Drug Testing and Analysis (2020) Vol. 12, Iss. 4, pp. 514-523
Closed Access | Times Cited: 33
Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders
Nicolas Fabresse, Laurie Gheddar, Pascal Kintz, et al.
Forensic Science International (2021) Vol. 322, pp. 110771-110771
Open Access | Times Cited: 29
Anabolic-androgenic steroids: procurement and administration practices of doping athletes
Julius Fink, Brad J. Schöenfeld, Anthony C. Hackney, et al.
The Physician and Sportsmedicine (2018) Vol. 47, Iss. 1, pp. 10-14
Closed Access | Times Cited: 36
Falsification of biotechnology drugs: current dangers and/or future disasters?
Steven Janvier, Bart De Spiegeleer, Céline Vanhee, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 161, pp. 175-191
Closed Access | Times Cited: 34
Ciências Forenses: Aplicações Científicas na Criminalística
Samara Alves Testoni, Cláudio M. P. Pereira, Rafael Scorsatto Ortiz
Revista Brasileira de Criminalística (2025) Vol. 14, Iss. 1, pp. 77-77
Open Access
Harm reduction in the Enhanced Games: Can performance enhancing drugs be ‘safe’?
Martin Chandler, Ian D. Boardley
Performance Enhancement & Health (2025) Vol. 13, Iss. 3, pp. 100341-100341
Open Access
A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids
Evelyn Frude, Fiona H. McKay, Matthew Dunn
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 24
Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology
Katja M. Shimko, Timothy Piatkowski, Kevin V. Thomas, et al.
Journal of Hazardous Materials (2021) Vol. 419, pp. 126340-126340
Open Access | Times Cited: 22
Prospective study on blood pressure, lipid metabolism and erythrocytosis during and after androgen abuse
Diederik L. Smit, Aldo Grefhorst, Madelon M. Buijs, et al.
Andrologia (2022) Vol. 54, Iss. 4
Open Access | Times Cited: 15
The Enhanced Games: Prohibition, harm reduction & the future of sport
Luke A. Turnock
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100295-100295
Open Access | Times Cited: 3
From a non‐targeted metabolomics approach to a targeted biomarkers strategy to highlight testosterone abuse in equine. Illustration of a methodological transfer between platforms and laboratories
Chloé Cloteau, Gaud Dervilly, Zied Kaabia, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 5, pp. 864-878
Open Access | Times Cited: 14
Health, Economic, and Social Impacts of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review of Methodological Approaches
Raimat Korede Salami, Sara Valente de Almeida, Adrian Gheorghe, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 2, pp. 228-240
Open Access | Times Cited: 8
Development of an ultra‐high performance liquid chromatography–tandem mass spectrometry method for the determination of anabolic steroids currently available on the black market in the Czech Republic and Slovakia
Barbora Tirčová, Zuzana Bosáková, Petr Kozlík
Drug Testing and Analysis (2018) Vol. 11, Iss. 2, pp. 355-360
Closed Access | Times Cited: 20
Novel wellbeing and repair peptide use in the UK: Netnographic findings
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Do you get what you see? The illicit doping market in Denmark—An analysis of performance and image enhancing drugs seized by the police over a 1‐year period
Pia Johansson Heinsvig, Ask Vest Christiansen, Daniel Ayoubi, et al.
Drug Testing and Analysis (2023) Vol. 15, Iss. 6, pp. 668-677
Open Access | Times Cited: 5
Uncovering the Quality Deficiencies with Potentially Harmful Effects in Substandard and Falsified PDE-5 Inhibitors Seized by Belgian Controlling Agencies
Céline Vanhee, B. Jacobs, Marcella Mori, et al.
Forensic Sciences (2023) Vol. 3, Iss. 3, pp. 426-451
Open Access | Times Cited: 5
Application of differential scanning calorimetry in the analysis of apprehended formulations of anabolic androgenic steroids
Lucas M. Berneira, S. C. de Freitas, Caroline Carapina da Silva, et al.
Forensic Science International (2019) Vol. 296, pp. 15-21
Closed Access | Times Cited: 13
Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP‐2) in a seized injection vial
Magdalena Popławska, Agata Błażewicz
Drug Testing and Analysis (2018) Vol. 11, Iss. 1, pp. 162-167
Open Access | Times Cited: 11
In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis
Katarzyna Kowalczyk, Julio César Torres Elguera, Anna Jarek, et al.
Drug Testing and Analysis (2021) Vol. 14, Iss. 1, pp. 122-136
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top